Location History:
- Pittsburgh, PA (US) (1998 - 1999)
- Wexford, PA (US) (1997 - 2011)
Company Filing History:
8 out of 1,862 
3 out of 1,248 
1 out of 9 Years Active: 1997-2011
Title: Ronald C Montelaro: Innovator in Antimicrobial Peptides and EIA Vaccines
Introduction
Ronald C Montelaro is a prominent inventor based in Wexford, Pennsylvania, known for his substantial contributions to the field of biomedical innovations. With a total of 14 patents to his name, Montelaro's work primarily focuses on antimicrobial peptides and vaccines that target infectious diseases.
Latest Patents
His most recent patents showcase significant advancements in two areas: virus-derived antimicrobial peptides and equine infectious anemia (EIA) vaccines. The antimicrobial peptides, identified as LBU, WLBU, and WR, are innovative analogs of the Lentivirus Lytic Peptide 1 (LLP1). These peptides have been shown to possess antimicrobial activity, capable of neutralizing various enveloped viruses, fungi, and bacteria. The applications of these peptides offer promising methods for treating and preventing infectious diseases.
In addition, Montelaro's EIA vaccine invention provides immunity to mammals, particularly equines, against equine infectious anemia virus (EIAV). This vaccine differentiates between vaccinated and non-vaccinated mammals, ensuring enhanced control over the spread of this disease. Notably, the vaccine has been engineered to prevent clinical disease and subsequent transmission, highlighting Montelaro's dedication to public health.
Career Highlights
Throughout his career, Ronald C Montelaro has collaborated with esteemed institutions, including the University of Pittsburgh and Akzo Nobel N.V. His work has greatly impacted the field of infectious disease management, contributing not only to academic research but also to practical applications in veterinary medicine.
Collaborations
Montelaro has worked alongside notable colleagues like Timothy A Mietzner and Charles Issel. Their collaborative efforts have furthered the exploration of novel therapeutic strategies and vaccine development.
Conclusion
Ronald C Montelaro stands out as a valuable contributor to the landscape of biomedical innovation, with a focus on antimicrobial solutions and vaccines. His extensive patent portfolio reflects his commitment to addressing some of the most pressing health challenges of our time, reinforcing the importance of research and collaboration in the pursuit of effective treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.